J. Corren

Poster Author Of 5 e-Posters

 ePosters
03. Asthma

A1287 - Impact of Intrinsic and Extrinsic Factors on the Variability of Blood Eosinophil Levels in Asthma

Presenter:
Date
05/19/2019
Room
Area E (Hall F, Level 2), KBHCCD
Session Name
A31 - ASTHMA: CLINICAL STUDIES I
Session Type
Thematic Poster Session
Authors
03. Asthma

A2621 - Tezepelumab Treatment Effect on Annualized Rate of Exacerbations by Baseline Biomarkers in Uncontrolled Severe Asthma Patients: Phase 2b PATHWAY Study

Presenter:
Date
05/20/2019
Room
Room C146 (Level 1), KBHCCD
Session Name
B15 - IMMUNOTHERAPY FOR LUNG DISEASE
Session Type
Mini Symposium
Authors
03. Asthma

A2622 - The Impact of Tezepelumab on Hospitalization and Emergency Department Visits in Patients with Severe Uncontrolled Asthma: Results from the Pathway Phase 2b Trial

Presenter:
Date
05/20/2019
Room
Room C146 (Level 1), KBHCCD
Session Name
B15 - IMMUNOTHERAPY FOR LUNG DISEASE
Session Type
Mini Symposium
Authors
03. Asthma

A2668 - Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study

Presenter:
Date
05/20/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
B21 - SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES
Session Type
RAPiD: Rapid Abstract Poster Discussion Session
Authors
03. Asthma

A7086 - Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma

Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD
Session Type
RAPiD: Rapid Abstract Poster Discussion Session
Authors